IMMUNOPATOGENETIC FEATURE OF THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN CHILDREN
Abstract
To determine the significance of cytokine profile management in normal and pathological conditions in children, in particular, in the immunopathogenetic development of chronic kidney disease. Conclusion:various properties of cytokine mediators serve to protect the body from infectious agents and repair tissues. First of all, cytokines regulate the development of local protective processes, cause the formation of an inflammatory reaction. Therefore, the composition and ratio of pro-inflammatory and anti-inflammatory cytokines can be considered as the most objective indicators of the inflammatory process and the growth of fibrosis. The prediction of an imbalance in the cytokine system can be used as a biomarker for chronic kidney disease, disease progression, and treatment efficacy. An analysis of the literature data revealed the scientific and practical significance of studying the cytokine status in chronic kidney disease.
About the Authors
List of references
Hogg R.J., Furth S., Lemeley K.V., Portman R., Schwartz G.J, Coresh J. et al. National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification and stratis-faction. Pediatrics 2003; 111(6): 1416–1421. DOI: 10.1542/peds.111.6.1416
Karimdzhanov I.A, Rakhmanova L.K, Iskanova G.N, Israilova N.A, Yusupova G.A., Karimova U. Arterial Hypertension in Children with Chronic Kidney Diseases. American Journal of Pediatrics. Special Issue: Chronic Kidney Disease in Children.2020; 6(2: 109-116. doi: 10.11648/j.ajp.20200602.18
Karimdzhanov I.A, Rakhmanova L.K, Iskanova G.N, Israilova N.A A Highly Effective Algorithm For Predicting Chronic Kidney Disease. In Children On The Background Of Atopia. International Journal of Advanced Science and technology.2020; 29(7): 3389-3394. http://sersc.org/journals/index.php/IJAST/article/view/21901
Ifuku M., Miyake K., Watanebe M., Ito K., Abe Y., Sasatomi Y. et al.Various roles of the cytokine mRNA expression in different forms of glomerulonephritis. Amer J Nephrol 2013; 38(2): 115–123. DOI: 10.1159/000353102
Suárez-Fueyo A., Bradley S.J., Klatzmann D., Tsokos G.C. T-cells and autoimmune kidney disease. Nat Rev Nephrol. 2017; 13: 329–343. DOI: 10.1038/ nrneph.2017.34
Oradova A.Sh., Ustenova G.O., Stabaeva G.S.Methods of cytokine research (review article). Medicine 2014; 10: 84–87.
Su H., Lei C.T., Zhang C. Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update. Front Immunol .2017; 8: 405. DOI: 10.3389/fimmu.2017.00405
Alwahaibi N., Alissaei H., Al-Kalbani A., Alabri N., Allawati Z., Albalooshi M. Evaluation of interleukin-2, interleukin-8, and tumor necrosis factor-like weak inducer of apoptosis in hemodialysis and renal transplant patients and healthy controls. Saudi J Kidney Dis Transpl 2016; 27(6): 1123–1128. DOI: 10.4103/1319-2442.194594
Stenvinkel P., Ketteler M., Johnson R.J., Lindholm B., Pecoits-Filho R., Riella M. et al.IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia––the good, the bad, and the ugly. Kidney Int 2005; 67(4): 1216–1233. DOI: 10.1111/j.1523-1755.2005.00200.x
Garlanda C. The interleukin-1 family: back to the future / C. Garlanda. C.A. Dinarcllo, A. Mantovani //Immunity - 2013. - Vol. 39.-JM. - P. 1003-1018.
Sinuani I., Beberashvili I., Averbukh Z., Sandbank J. Role of IL-10 in the progression of kidney disease. World J Transplant 2013; 3(4): 91–98. DOI: 10.5500/wjt.v3.i4.91
Huang H.Y. Interleukin (IL)-Ip regulation of Il-lp and IL-1 receptor antagonist expression in cultured human endometrial stromal cells / H.Y.Huang // J. Clin. Endocrinol. Ylctab. - 2009. - Vol. 86. - P. 1387-1393.
Khatri S, Bajeer IA, Tresa V, Hashmi S. Short-term outcome of clinical and histopathologic variants of mesangiocapillary glomerulonephritis in children: A retrospective analysis from a tertiary care center. J Pak Med Assoc. 2018 Aug; 68(8):1199-1204.
Kidney Diseases: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Pratice Guideline for glomerulonephritis. Kidney Int Suppl 2012; 2(2):139-274.
Zorin I.V., Vyalkova A.A., Gun’kova E.V., Kucenko L.V., Plotnikova S.V., Chesnokova S.A. et al.The role of cytokines and growth factors in the formation and progression of chronic kidney disease in children. Lechashchii vrach 2019. https://www.lvrach.ru/2019/09/15437371
Liu Q.The molecular mechanisms of TLR-signaling cooperation in cytokine regulation /Q. Liu. J.L. Ding //Immunol. Cell. Biol. - 2016. - Vol. 94. - №6. - P. 538-542.
Paunova S.S.Children’s nephrology.Textbook. Moscow: MEDpress-inform, 2018; 466–467.
Ignatova M.S.Children’s nephrology. A guide for doctors. Moscow: OOO «Medicinskoe informacionnoe agentstvo», 2011; 696.
Drannik G.N., Driyanskaya V.E., Gajsenyuk F.Z., Rudenko M.Yu., Stepanova N.M., Bagdasarova I.V. et al. Factors of intercellular cooperation in the immunogenesis of pyelonephritis. Immunologiya, allergologiya, infektologiya 2013; 1: 13–19.
Utc I.A., Zaharova N.B., Kostina M.L.Modern aspects of intercellular interactions and their role in the genesis of tubulointerstitial nephropathies. Saratovskii nauchno-medicinskii zhurnal.2007; 3(3): 44–49.
Morozov D.A., Morrison V.V., Morozova O.L., Lakomova D.Yu. Pathogenetic principles and modern possibilities of early diagnosis of nephrosclerosis in children with vesicoureteral reflux. Saratovskii nauchno-meditsinskii zhurnal 2011; 7(1):151–157.
Koren’kov D.G., Pavlova A.L.Cytokines in determining the severity of the active phase of chronic pyelonephritis. Vestnik urologii 2017; 5(3):14–21. DOI: 10.21886/2308-6424-2017-5-3-14-21
Ortega L., Fornoni A. Role of cytokines in the pathogenesis of acute and chronic kidney disease, glomerulonephritis, and end-stage kidney disease. Int J Interferon Cytokine Mediat Res 2010; 2(1): 49–62. DOI: 10.2147/IJICMR.S10111
Simões e Silva A.C., Valério F.C., Vasconcelos M.A., Miranda D.M., Oliveira E.A.Interactions between Cytokines, Congenital Anomalies of Kidney and Urinary Tract and Chronic Kidney Disease. J Immunol Res 2013; 2013: 597920. DOI: 10.1155/2013/597920
Merkodanova Yu.A.Urine cytokine profile in various etiopathogenetic variants of chronic pyelonephritis in children. Saratovskij nauchno-meditsinskij zhurnal 2011; 7(4): 901–904.
Hvorostov I.N., Zorkin S. N., Smirnov E.I.The value of determining the levels of cytokines in obstructive uropathies in children. Vestnik VolGMU 2005; 2: 45–49.
Tullus K., Sjoberg P. Epidemiological Aspects of P-Fimbriated E. coli. Acta Paediatr Scand 1986; 75(2): 205–210. DOI: 10.1111/j.1651-2227.1986.tb10185.x
Bychkovskih V.A.Assessment of the level of cytokines in the blood serum of patients with chronic pyelonephritis of a single kidney in the early postoperative period. Kurskii nauchno-prakticheskii vestnik «Chelovek i ego zdorov’e» (Kursk Scientific and Practical Bulletin «Man and His Health») 2011; 3: 42–45.
Zaharova N.B., Grazhdanov R.A., Ponukalin A.N., Inozemceva N.D., Rossolovskij A.N.Diagnostic value of pro- and anti-inflammatory citokines in urine at an yexacerbation of chronic calculous pyelonephritis. Byulleten’ medicinskih Internet-konferencij (Internet Medical Bulletin).2013; 3(4): 835–838.
Lopez-Novoa J.M., Rodriguez-Pena A.B., Ortiz A. et al. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implica-tions. J Transl Med 2011; 9:13. Published online 2011 Jan 20. doi: 10.1186/1479-5876-9-13.
Slobodyan E.I., Kaladze N.N., Govdalyuk A.L. Urine cytokines are non-invasive markers of clinical laboratory remission in children with chronic pyelonephritis. Nefrologiya 2017; 21(2): 73–82. DOI: 10.24884/1561-6274-2017-21-2-73-82
Renata Y., Jassar H., Katz R., Hochberg A., Nir R.R., KleinKremer A. Urinary soncentration of sytokines in shildren with acute pyelonephritis. Eur J Pediatr 2013; 72(6): 769–74. DOI: 10.1007/s00431-012-1914-2
Lipiec K., Adamczyk P., ŚwiŚtochowska E., Ziora K., Szczepańska M.L-FABP and IL-6 as markers of chronic kidney damage in children after hemolytic uremic syndrome. Adv Clin Exp Med 2018; 27(7): 955–962. DOI: 10.17219/acem/70567
Karzakova L.M., Kudryashov S.I., Shestipalova M.V., Leontyeva E.V. Determining of cytokine levels in the urine in clinical practice. Klin Lab Diagn 2019; 64(5): 287–293. DOI: 10.18821/0869-2084-2019-64-5-287-293
Beglyarov R.O. Pro- and anti-inflamattory cytokines in children with various clinical forms of chronic glomerulonephritis. Kazanskii medicinskii zhurnal 2017; 98(6): 943–948.
Zwiech R. Predictive value of conjointly examined IL-1ra, TNF-RI, TNF-RII, and RANTES in patients with primary glomerulonephritis. J Korean Med Sci 2013; 28(2): 261–267. DOI: 10.3346/jkms.2013.28.2.261
Zhiznevskaya I.I., Hmelevskaya I.G. Peculiarities of the cytokine profile in glomerulopathy in children. Kurskii nauchno-prakticheskii vestnik «Chelovek i ego zdorov’e» (Kursk Scientific and Practical Bulletin «Man and His Health») 2013; 1: 62–66.
Anders H.J.Of inflammasomes and alarmins: IL-1βand IL-1αin Kidney Disease. J Am Soc Nephrol 2016; 27(9): 2564–2575. DOI: 10.1681/ASN.2016020177
Nagarajan M, Dineshkumar T, Balasubramaniyan T. Crescentic infection related glomerulonephritis in adult and its outcome. Saudi J Kidney Dis Transpl. 2018 May-Jun;29(3):623-629.
Kolesnyk M., Driyanska V., Velichko M., Drannik G., Savchenko V. Peculiarities of cytokines and their prognostic value in patients with chronic glomerulonephritis. Ukr J Nephrol.Dial 2013; 3(39). DOI: 10.31450/ukrjnd.3(39).2013.04
Latifova N.F., Efendiev A.M., Bagirova S.A., Dzhafarova G.A., Gafarov I.A. Study of cytokines and antimicrobial peptides in patients with chronic kidney diseases. Sovremennye problemy nauki i obrazovaniya 2019; 4: 20. DOI: 10.17513/spno.29031
Couser W.G. Basic and Translational Concepts of Immun-Mediated Glomerular Diseases /W.G. Couser Hi. Am. Soc. Nephrol. - 2012. - Vol. 23. - LgZ. - P. 381-399.
Murkamilov I.T., Ajtbaev K.A., Fomin V.V., Murkamilova Zh.A., Sabirov I.S., Rajimzhanov Z.R. et al. Pro-inflammatory cytokines in patients with chronic kidney disease: focus on interleukin-6.
Malyshev M.E., Bel’skih O.A., Sorokina A.A., Zubor O.I. The information content of the cytokine profile of blood serum and salivary fluid in patients with chronic kidney disease. Kurskii nauchno-prakticheskii vestnik «Chelovek i ego zdorov’e» (Kursk Scientific and Practical Bulletin «Man and His Health») 2016; 1: 44–49.
Raxmanova, L.K., Raxmanov .A.M. Assessment of immunopathological developments in children with nephrotic syndrome with background pathology. International Journal of Scientific Pediatrics. 2022; 08 ( 03). P.16-22.
Rakhmanova L.K., Savenkova N.D., Iskandarova I.R. Immune-hematological risks of progression of chronic kidney disease in children with lymphatic diathesis. Journal of Xi`an Shiyou University, Natural Science Edition. 2020. Vol.16, Issue 10. R.297-311. www.xisdxjxsu.asia
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
